Silver Spring’s Aziyo Biologics laying off 12% of workforce

Silver Spring’s Aziyo Biologics Inc. (NASDAQ: AZYO) is laying off a chunk of its workforce, the latest in a string of local biotechs shaving their headcounts to bank more cash. The company initiated a “a significant reduction” in its workforce earlier this week that will affect about 12% of its workforce, Chief Financial Officer Matt Ferguson said on a fourth-quarter earnings call Wednesday.